Cramer's Morning Take: Eli Lilly 8/7/25

Cramer reacts to this pharma giant’s drug trial that failed to impress. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake CNBC Investing Club Disclaimer